BioSpace News Archive

COVID-19 dashboard provides real-time laboratory data and hospital bed management for accurate monitoring and case reporting

Customers can conveniently order select retail products online in advance for pick-up at Walgreens pharmacy drive-thrus

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that it has completed a medical manual that is pivotal to the completion of its Investigational New Drug application (IND) filing. The manual, “Angiography Manual – Transarterial Chemoinfusion of the Pa

Junshi Biosciences (HKEX: 1877) and Eli Lilly and Company (NYSE: LLY) announced today they have entered into an agreement to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. At the beginning of the COVID-19 outbreak, Junshi Biosciences—a China-based biopharmaceutical company specializing in discovery, development and commercialization of

ZOLL ® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today it has received CE Mark approval to market and distribute its SuperSaturated Oxygen (SSO 2 ) Therapy System in Europe. SSO 2 Therapy provides interventional cardiologists with the first and only clinically proven treatment beyond percutaneous coronary intervention (PCI) to signifi

A new study published in The Journal of Infectious Diseases showed high rates of GBS infection among the elderly, African Americans, and people with chronic conditions

Titan Medical Announces US$2.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Company Launches #INKEDforALS Campaign in its Commitment to Raising Awareness for the ALS Community During ALS Awareness Month

Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will make a virtual presentation at BofA Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 1:00 p.m. ET. The audio portion of the presentation will be available on the investors page of the Coherus BioSciences website at https://investors.coherus.com . About Coherus BioSciences, Inc. Coherus is a leading biosimilar company

Abstracts originally accepted for 2020 Digestive Disease Week Conference – to be published online